Harshest Breast Cancer Chemo Regimens Could Cost Survivors 9.4 Years of Life Through Faster Biological Aging, Georgetown Model Estimates
A Georgetown Lombardi simulation published in JAMA Network Open estimates the most cytotoxic breast cancer chemotherapy regimens accelerate biological aging enough to cost survivors 9.4 remaining life years on average, putting survivorship care, biological age testing and senolytics in the spotlight.
Read more